Our story
Luna started with the night: a question a child asked a parent, and nights a founder had lived for decades.

It started with a question
In 2008, Jon Brilliant's child Myla was diagnosed with type 1 diabetes. Not long after, Myla asked a question Jon couldn’t answer well:
"I know if my blood sugars go low, I can go into a coma. How do I know I will wake up at night if my blood sugars go low?"
For John Sjölund, the challenges of managing diabetes overnight were familiar. Diagnosed with type 1 diabetes at four, he had lived through every change since: twice-daily injections, then pens, better insulins, and CGM. About ten years ago, alone at night in an apartment in Stockholm, John built a system to automate insulin overnight.
The mornings changed. John woke up in range, the alarms almost stopped, and the nighttime bathroom trips ended. In John's words, it was life-changing for the whole family.
John and Jon started Luna with co-founder Sean Saint to build an overnight system for people who use insulin pens. Luna is an investigational device, not the system John built for himself.
The night was the part nobody solved
Automation already existed. It came with a trade-off: wear a pump all day and all night.
For many people who take insulin with pens, wearing a pump 24/7 isn’t appealing. 65% of adults with type 1 and 53% with type 2 on multiple daily injections give the time it takes, the complexity, discomfort, or not wanting a device on the body as highly impactful reasons for not using a pump.1 Only 5% say they're highly or extremely likely to start a pump within the next 12 months.2
Their nights did not get easier. 79% of adults with type 1 diabetes on multiple daily injections and CGM say diabetes interrupts their sleep at least occasionally.3 Nearly a third of people go to bed with their glucose high on purpose, to avoid going low while they sleep.4
So we’re building for the night
Luna is sleep-only automation for people who take insulin with pens. It steps in when you close your eyes and steps back when you open them. During the day, there is nothing to wear.
Luna is an investigational device and is not yet available.
Sources
- dQ&A, PWD Survey Results: Luna Patient Segmentation & Jobs To Be Done, January 2026, n=583, slide 41.
- dQ&A, PWD Survey Results: Luna Patient Segmentation & Jobs To Be Done, January 2026 (fieldwork 13–19 December 2025), slide 39; adults with type 1 or type 2 diabetes on multiple daily injections and CGM, n=406. 5% chose highly or extremely likely to start a pump in the next 12 months; 95% did not. This is not a measure of whether they are considering a pump.
- dQ&A, PWD Survey Results: Luna Patient Segmentation & Jobs To Be Done, January 2026 (fieldwork 13–19 December 2025), slide 53; adults with type 1 diabetes on multiple daily injections and CGM, n=219; diabetes-related interruption occasionally or more often in a typical week.
- dQ&A, PWD Survey Results: Luna Patient Segmentation & Jobs To Be Done, January 2026, n=583, cited in dQ&A, Luna Product Positioning with HCPs and JTBD, March 2026, n=22, slide 9.
Be the first to know when Luna launches
Luna is not yet available. We’ll let you know when there’s news.
Sign up for updates